Vinorelbine

Vinorelbine
Vinorelbine
Systematic (IUPAC) name
4-(acetyloxy)- 6,7-didehydro- 15-((2R,6R,8S)-4-ethyl- 1,3,6,7,8,9-hexahydro- 8-(methoxycarbonyl)- 2,6-methano- 2H-azecino(4,3-b)indol-8-yl)- 3-hydroxy- 16-methoxy- 1-methyl- methyl ester,
Clinical data
Trade names Navelbine
AHFS/Drugs.com monograph
MedlinePlus a695013
Pregnancy cat. D(AU) D(US)
Legal status POM (UK) -only (US)
Routes intravenous, oral
Pharmacokinetic data
Bioavailability 43 ± 14% (oral)[1]
Protein binding 79 to 91%
Metabolism Hepatic (CYP3A4-mediated)
Half-life 27.7 to 43.6 hours
Excretion Fecal (46%) and renal (18%)
Identifiers
CAS number 71486-22-1 YesY
ATC code L01CA04
PubChem CID 5311497
DrugBank APRD00101
ChemSpider 4470974 YesY
UNII Q6C979R91Y N
KEGG D08680 N
ChEMBL CHEMBL607994 N
Chemical data
Formula C45H54N4O8 
Mol. mass 778.932 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Vinorelbine (trade name Navelbine) is an anti-mitotic chemotherapy drug that is given as a treatment for some types of cancer, including breast cancer and non-small cell lung cancer.

Contents

Pharmacology

Vinorelbine is the first 5´NOR semi-synthetic vinca alkaloid. It is obtained by semi-synthesis from alkaloids extracted from the rosy periwinkle, Catharanthus roseus.

History

Vinorelbine was invented by the pharmacist Pierre Potier and his team from the CNRS in France in the 1980s and was licensed to the oncology department of the Pierre Fabre Group. The drug was approved in France in 1989 under the brand name Navelbine for the treatment of non-small cell lung cancer. It gained approval to treat metastatic breast cancer in 1991. Vinorelbine received approval by the United States Food and Drug Administration (FDA) in December 1994 sponsored by Burroughs Wellcome Company. Pierre Fabre Group now markets Navelbine in the U.S., where the drug went generic in February 2003.

In most European countries, vinorelbine is approved to treat non-small cell lung cancer and breast cancer.

Uses

As stated above, Vinorelbine is approved for the treatment of Non small cell lung cancer and Metastatic breast cancer. It is also active in rhabdomyosarcoma.[2]

Oral formulation

An oral formulation has been marketed and registered in most European countries for the same settings. It has similar efficacy as the intravenous formulation, avoids venous toxicities of an infusion and is easier to take.

Side effects

Vinorelbine has a number of side-effects that can limit its use:

Lowered resistance to infection, bruising or bleeding, anaemia, constipation, diarrhoea, nausea, numbness or tingling in hands or feet (peripheral neuropathy), tiredness and a general feeling of weakness (asthenia), inflammation of the vein into which it was injected (phlebitis). Seldom severe hyponatremia is seen.

Less common effects are hair loss and allergic reaction.

References

  1. ^ Marty M, Fumoleau P, Adenis A, Rousseau Y, Merrouche Y, Robinet G, Senac I, Puozzo C (2001). "Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors". Ann Oncol 12 (11): 1643–9. doi:10.1023/A:1013180903805. PMID 11822766. 
  2. ^ Casanova, M; Ferrari, A; Spreafico, F; Terenziani, M; Massimino, M; Luksch, R; Cefalo, G; Polastri, D et al. (2002). "Vinorelbine in previously treated advanced childhood sarcomas: Evidence of activity in rhabdomyosarcoma". Cancer 94 (12): 3263–8. doi:10.1002/cncr.10600. PMID 12115359. 

Wikimedia Foundation. 2010.

Игры ⚽ Нужно сделать НИР?

Look at other dictionaries:

  • Vinorelbine — Général Nom IUPAC ester de 4 (acétyloxy) 6,7 didéhydro 15 ((2R,6R,8S) 4 éthyl 1,3,6,7,8,9 hexahydro 8 (méthoxycarbonyl) 2,6 méthano 2H azecino(4,3 b)indol 8 yl) 3 hydroxy 16 …   Wikipédia en Français

  • Vinorelbine — Strukturformel Allgemeines Freiname Vinorelbin Andere Namen …   Deutsch Wikipedia

  • vinorelbine — noun A particular antitumor drug …   Wiktionary

  • vinorelbine — n.; see vinca alkaloid …   The new mediacal dictionary

  • vinorelbine — An anticancer drug that belongs to the family of plant drugs called vinca alkaloids …   English dictionary of cancer terms

  • vinorelbine tartrate — vi·no·rel·bine tar·trate (vĭ norґel bēn) [USP] a semisynthetic vinca alkaloid derived from vinblastine, used as an antineoplastic in the treatment of non–small cell lung carcinoma; administered intravenously …   Medical dictionary

  • 71486-22-1 — Vinorelbine Vinorelbine Général No CAS …   Wikipédia en Français

  • C45H54N4O8 — Vinorelbine Vinorelbine Général No CAS …   Wikipédia en Français

  • Navelbine — Vinorelbine Vinorelbine Général No CAS …   Wikipédia en Français

  • Discovery and development of tubulin inhibitors — Tubulin inhibitors interfere directly with the tubulin system which is in contrast to those drugs acting on DNA for cancer chemotherapy. Microtubules play an important role in eukaryotic cells. Alpha and beta tubulin, the main components of… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”